Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Professor Saad Shakir
With
Merck Sharp & Dohme LLC
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients prescribed asenapine for any indication by NHS GPs in England.
Patients for whom a study questionnaire containing useful information has been returned, will be included in the study cohort regardless of the dose or frequency of administration of asenapine, and irrespective of whether any medicines are concurrently administered.
You may not be if
patient no longer registered with the practice
patient for whom no information is provided on study questionnaire
patients for whom information provided on study questionnaire relates to another antipsychotic drug
patients for whom the index date is an improbable date (i.e. before market launch date)
patients for whom the GP reports that the patient did not take or was never prescribed asenapine
Clareo Health | An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)
